共查询到20条相似文献,搜索用时 15 毫秒
1.
M. A. Luchelli-Fortis S. Z. Langer 《Naunyn-Schmiedeberg's archives of pharmacology》1975,287(3):261-275
Summary The metabolism of 3H-noradrenaline released by nerve stimulation in the isolated nerve-muscle preparation of the cat nictitating membrane was determined under control conditions and in the presence of hydrocortisone, 28 M, a concentration which inhibits the high affinity extraneuronal uptake of noradrenaline in this tissue. in the controls the main fraction in the overflow elicited by stimulation at 10 Hz during 2 min was the deaminated glycol, 3H-DOPEG (3,4-dihydroxyphenylglycol), which accounted for 45.2±2.96% of the total radioactivity. Under these conditions, 3H-noradrenaline represented 30.8±1.92%, while 3H-normetanephrine accounted for 14.5±0.94% of the total overflow of radioactivity. During exposure to hydrocortisone there was a selective inhibition in 3H-normetanephrine formation from 3H-noradrenaline released by stimulation while the other fractions were not affected significantly. In contrast to these results, there were no changes in the spontaneous outflow of 3H-normetanephrine during exposure to hydrocortisone. The results obtained support the view that 3H-normetanephrine in sponteneous release originates from the activity of prejunctional catechol-O-methyltransferase. On the other hand, 3H-normetanephrine formed during transmitter release elicited by nerve stimulation is due to the activity of extraneuronal catechol-O-methyltransferase. Access of 3H-noradrenaline released by nerve stimulation to extraneuronal catechol-O-methyltransferase is mediated through the high-affinity, hydrocortisone-sensitive extraneuronal uptake mechanism. 相似文献
2.
Arie H. Mulder Cees D. J. de Langen Victoria de Regt François Hogenboom 《Naunyn-Schmiedeberg's archives of pharmacology》1978,303(2):193-196
Summary The effects of oxymetazoline and noradrenaline (in the presence of desipramine) on the release of 3H-noradrenaline from rat brain cortex synaptosomes were studied using a superfusion technique. Both drugs (at 1M concentrations) were found to reduce the depolarization-induced (15 mM K+) release of 3H-noradrenaline. The release-modulating effect of noradrenaline was antagonized by phentolamine and yohimbine.The data provide direct evidence for the hypothesis that -receptors modulating the release of noradrenaline are localized on varicosities of central noradrenergic neurones. 相似文献
3.
G. Haeusler 《Naunyn-Schmiedeberg's archives of pharmacology》1974,286(1):97-111
Summary The effects of clonidine on blood pressure, heart rate, contractile state of the nictitating membranes, spontaneous sympathetic nerve activity and response of sympathetic nerves to hypothalamic stimulation were compared in normal anaesthetized cats and in anaesthetized cats pretreated with reserpine and -methyl-p-tyrosine. The pretreatment lowered the noradrenaline content of various parts of the brain to less than 5 ng/g, i.e. to less than 1–3% of that of the controls. Under the conditions of this severe noradrenaline depletion, blood pressure and heart rate were low and spontaneous sympathetic nerve activity consisted of continous, high-amplitude discharges which contrasted with the low-amplitude bursts of activity—synchronous with the respiration—of the controls. In contrast to the controls, clonidine did not lower blood pressure and heart rate in the cats with noradrenaline depletion; however, the clonidine-induced contractions of the nictitating membranes were of similar magnitude and duration in both groups of animals. The efficacy of clonidine in reducing or abolishing spontaneous sympathetic nerve activity and in inhibiting the response of sympathetic nerves to hypothalamic stimulation was equal in controls and in cats with noradrenaline depletion, its potency being 3-fold higher in the former. The results indicate a direct stimulation of -adrenoceptors by clonidine both in the periphery and in the central nervous system and make it unlikely that the central effect of clonidine on blood pressure is due to a release of noradrenaline from central adrenergic neurones. It is further concluded that clonidine activates an adrenergic mechanism in the central nervous system by stimulation of postsynaptic -adrenoceptors. The inhibition of such a mechanism as a consequence of a diminished noradrenaline release due to stimulation of presynaptic -adrenoceptors—as proposed from in vitro experiments—seems to be of no importance for the central effect of clonidine on sympathetic nerve activity and blood pressure.Preliminary results have been presented at the 15th Spring Meeting of the German Pharmacological Society in Mainz (Haeusler, 1974a). 相似文献
4.
Maura Guido Pittaluga Anna Ricchetti Annamaria Raiteri Maurizio 《Naunyn-Schmiedeberg's archives of pharmacology》1984,327(1):86-89
Summary The interaction between clonidine, as an agonist at the 2-autoreceptors regulating noradrenaline release, and inhibitors of noradrenaline neuronal uptake was investigated in superfused synaptosomes, i.e. in conditions preventing accumulation of the released transmitter in the vicinity of presynaptic autoreceptors. Desipramine or cocaine did not decrease the inhibitory action of clonidine on the release of 3H-noradrenaline evoked by 15 mM KCl from rat cortex synaptosomes, even when the concentration ratio between uptake inhibitor and clonidine was very high. The present results do not support either the hypothesis of an interaction between imidazolines and noradrenaline uptake inhibitors at the level of 2-autoreceptors, or that of a functional coupling between presynaptic 2-autoreceptors and noradrenaline uptake mechanism. 相似文献
5.
Key Dismukes Augustinus A. De Boer Arie H. Mulder 《Naunyn-Schmiedeberg's archives of pharmacology》1977,299(2):115-122
Summary Brain cortical slices were superfused with Krebs-Ringer media and the effects of oxymetazoline (an -adrenoceptor agonist) and phentolamine (an -antagonist) on depolarization-induced 3H-NA release were examined. Depolarization was effected by various K+-concentrations or by electrical pulses.The effects of the -receptor agents on stimulated 3H-NA overflow appeared to be dependent on the strength of the depolarizing stimulus. Thus, at low K+-concentrations (13 or 26 mM) oxymetazoline decreased and phentolamine increased the stimulated overflow, while at 56 mM K+ little or no modulation was found. The agents acting on -receptors modulated 3H-NA release in a dose-dependent way (5 · 10–8–10–5 M).The lack of modulation by oxymetazoline of 3H-NA release induced by 56 mM K+ seems not to be due to a high concentration of NA released into the synaptic cleft, since reduction of the endogenous NA level by pretreatment with -methyl-para-tyrosine did not reveal such modulation.However, oxymetazoline was found to decrease 56 mM K+-induced 3H-NA release effectively, if the Ca2+-concentration in the medium was lowered from 1.2 to 0.2 mM. This suggests that -receptor mediated modulation of release may occur as a result of a change in Ca2+-availability to the depolarization-secretion process. In addition, hyperpolarization of nerve endings might be involved in the modulatory process, as concluded from calculations of the (theoretical) trans-membrane potential at various K+-concentrations.Although the -receptors modulating NA release seem to be localized presynaptically, their precise location remains uncertain. Experiments with tetrodotoxin suggested that the -receptor mediated modulation does not operate via a local interneuronal loop. 相似文献
6.
R. A. Lefebvre J. L. Willems M. G. Bogaert 《Naunyn-Schmiedeberg's archives of pharmacology》1984,326(1):22-28
Summary The mechanism of the inhibitory effect of dopamine on canine stomach fundus was studied in longitudinal and circular muscle fundus strips, contracted by transmural electrical stimulation or by methacholine.Results obtained for longitudinal and circular strips were similar. Dopamine (1 · 10–6–1 · 10–4 M) concentration-dependently inhibited frequency-response curves to electrical stimulation; these concentrations did not change the resting tone of the strips. Dopamine (1 · 10–4 M), tested on contractions of similar amplitude induced in the same strips by electrical stimulation at 0.5 Hz and by methacholine, inhibited the electrically induced contractions but had little influence on the contractions induced by methacholine. The inhibition of the electrically induced contractions by dopamine 1 · 10–4 M was not influenced by the presence of cocaine 3 · 10–5 M or hydrocortisone 3 · 10–5 M.The 1- and 2-adrenoceptor antagonist phentolamine and the 2-adrenoceptor antagonist rauwolscine markedly antagonized the inhibitory effect of dopamine on the response to electrical stimulation at 0.5 Hz. The 1-adrenoceptor antagonist prazosin and the dopamine receptor antagonists haloperidol and domperidone had no effect. The dopamine receptor antagonist metoclopramide decreased the inhibitory effect of dopamine but had a similar effect on the inhibition caused by noradrenaline.These results indicate that the inhibitory effect of dopamine in the dog gastric fundus is mainly mediated by an interaction with 2-adrenoceptors on the intramural cholinergic neurons; this effect is largely direct since it was not influenced by cocaine. These results are different from those obtained in the rat gastric fundus, where the inhibitory effect of dopamine is mainly indirect, and due to an interaction with -adrenoceptors on the intramural cholinergic neurons and with -adrenoceptors on the smooth muscle cells.
Dedicated to Prof. Dr. E. J. Ariëns (Department of Pharmacology, University of Nijmegen, The Netherlands) on the occasion of his retirement 相似文献
7.
Erik Skoubo-Kristensen Jan Fryklund 《Naunyn-Schmiedeberg's archives of pharmacology》1985,330(1):37-41
Summary Isolated gastric glands from the rabbit were used for studying the effect of catecholamines on the release of pepsinogen. Isoprenaline, adrenaline and noradrenaline stimulated pepsinogen release in a dose-dependent manner with similar maximal effects, but isoprenaline was significantly more potent than the other two agonists. The effect was mediated through -adrenoceptors, since the response was inhibited by the -adrenoceptor antagonist, propranolol, and since the -adrenoceptor agonist, phenylephrine, was without effect in the concentration range 0.01–10 M.Concentration-response curves for isoprenaline were shifted to the right in parallel by increasing doses of propranolol, and maximal response was not influenced by propranolol per se, which indicates a competitive type of antagonism. A Schild plot showed a pA2-value for propranolol of 7.70 and the slope of the regression line was 1.02. Studies with the 1-selective antagonist pafenolol and the 2-selective antagonist ICI 118.551 demonstrated that isoprenaline acted through 1-adrenoceptors. The results suggest an adrenergic component in the control of the peptic cells in rabbit gastric mucosa. 相似文献
8.
J. H. Schwieler T. Kahan J. Nussberger P. Hjemdahl 《Naunyn-Schmiedeberg's archives of pharmacology》1991,343(2):166-172
Summary The physiological importance of interactions between angiotensin II and sympathetic neurotransmission was studied in an in vivo model with constant flow blood perfused gracilis muscle in situ in dogs pretreated with desipramine and atropine. Sympathetic nerve stimulation- (2 and 8 Hz, 480 pulses) evoked overflow of endogenous noradrenaline and vasoconstriction, and vasoconstrictor responses to exogenous noradrenaline (0.5 nmol, locally i. a.) were evaluated.Angiotensin converting enzyme inhibition by benazeprilat (10 mg i. v.; n = 8) reduced arterial angiotensin II levels from 26 ± 8 to 2 +- 1 pM and reduced mean arterial and basal muscle perfusion pressures. Subsequent resubstitution of angiotensin II (3, 30 and 90 ng kg–1 min–1 i.v.) elevated arterial angiotensin II dose-dependently (to 67 ± 14, 622 ± 63 and 1940 ± 251 pM, respectively), as well as mean arterial and muscle perfusion pressures. Nerve stimulation-evoked noradrenaline overflow was unchanged following benazeprilat (–4 ± 4 and + 1 ± 8% at 2 and 8 Hz, respectively) and during subsequent infusions of angiotensin II. Vasoconstrictor responses to nerve stimulation and exogenous noradrenaline were also uninfluenced by these treatments. Thus, angiotensin II did not enhance sympathetic neurotransmission at the postjunctional level.Another group of animals was pretreated with noncompetitive -adrenoceptor blockade locally by phenoxybenzamine and benextramine (0.5 mg kg–1 i. a. of each; n = 7), which abolished vasoconstrictor responses to nerve stimulation. The effects of benazeprilat and subsequent angiotensin II infusions (3 and 30 ng kg–1 min–1 i.v.) on circulating angiotensin II levels, mean arterial and muscle perfusion pressures were similar in this group. Following -adrenoceptor blockade, however, inhibition of angiotensin converting enzyme reduced sympathetic nerve stimulation-evoked noradrenaline overflow by 23 ± 4 and 21 ± 5% at 2 and 8 Hz, respectively (P < 0.01 for both). Angiotensin II infusions failed to enhance evoked noradrenaline overflow (–5 ± 10 and –18 ± 10% at 2 Hz; +6 ± 13% and –3 ± 14% at 8 Hz) also under these conditions.It is concluded that circulating angiotensin II does not influence sympathetic vascular control in canine skeletal muscle even at very high levels in arterial plasma. Angiotensin converting enzyme inhibition reduces nerve stimulation-evoked noradrenaline overflow only in the presence of -adrenoceptor blockade, suggesting that prejunctional -adrenoceptors have an overriding importance over prejunctional angiotensin II-receptors in the modulation of noradrenaline release in this model. The effect of converting enzyme inhibition may be related to merely local changes in angiotensin II concentration or — unrelated to the renin-angiotensin system — to other consequences of the blockade of this unspecific enzyme.
Send offprint requests to J. Schwieler at the above address 相似文献
9.
C. Bohmann P. Schollmeyer L. C. Rump 《Naunyn-Schmiedeberg's archives of pharmacology》1994,349(2):118-124
The aim of the present study was to investigate whether or not activation of imidazoline receptors modulates noradrenaline release in the rat isolated kidney. Kidneys were pre-exposed to 3H-noradrenaline and the renal nerves were stimulated with 6 pulses at 100 Hz. The stimulation induced (S-I) outflow of radioactivity was taken as an index of endogenous noradrenaline release. The imidazoline derivatives clonidine (1–1000 nmol/l) and moxonidine (10–1000 nmol/l) inhibited S-I outflow of radioactivity with an EC50 of 6.8 nmol/l and 62.5 nmol/l and a maximum of 88% and 97%, respectively. The concentration response curves for clonidine and moxonidine were shifted to the right by the selective 2-adrenoceptor antagonist rauwolscine (0.1 mol/l) in a parallel manner with identical pKB's of 8.52 and 8.46, respectively. Furthermore, the -adrenoceptor agonist (–)--methylnoradrenaline (0.1–30nmol/l), which has no affinity for imidazoline binding sites, inhibited S-I outflow of radioactivity with an EC50 of 2.4 nmol/l and a maximum of 94%. Rauwolscine (0.1 mol/l) again shifted the concentration response curve for this -adrenoceptor agonist to the right with a pKB of 8.40. Moreover, the selective 2-adrenoceptor antagonist 2-[2-(2-methoxy-1,4-benzodioxanyl)]imidazoline HCl(RX 821002,0.01 mol/l) shifted the concentration response curves for clonidine and moxonidine to the right with pKB's of 9.46 and 9.18, respectively. The 2-adrenoceptor antagonist 4-chloro-2-(2-imidazoline-2-ylamino)-isoindoline HCl (BDF 6143, 1–1000 nmol/l), which, in the presence of 2-adrenoceptor blockade, has been shown to inhibit noradrenaline release through activation of imidazoline receptors, inhibited S-I outflow of radioactivity with an EC50 of about 20.5 nmol/l (with 1000 nmol/l producing 60% inhibition). The inhibitory effects of BDF 6143 and clonidine were abolished after pretreatment of the kidneys with the irreversible 2-adrenoceptor antagonist phenoxybenzamine (1 mol/l). However, RX 821002 did not alter and rauwolscine slightly antagonized the inhibitory effect of BDF 6143. It is concluded that the imidazoline derivatives clonidine and moxonidine as well as the phenylethylamine (–)--methylnoradrenaline inhibit noradrenaline release in rat isolated kidney exclusively through activation of prejunctional 2-adrenoceptors. BDF 6143 inhibits noradrenaline release in rat isolated kidney through an 2-adrenoceptor-independent, possibly an imidazoline receptor mechanism.
Correspondence to: L. C. Rump at the above address 相似文献
10.
Summary Plasma catecholamine levels were determined in pithed rats during electrical stimulation of the entire sympathetic nervous system. In animals treated chronically with clorgyline (1 mg/kg daily for 21 days) the increment in plasma norepinephrine concentration during stimulation was greather than in control animals, whereas a single dose of clorgyline (2 mg/kg 2 h before pithing), which produced the same degree of inhibition of arterial MAO type A and a similar increase in arterial norepinephrine content, had no effect on the plasma norepinephrine response to stimulation. Injection of yohimbine (1 mg/kg) produced the same degree of enhancement of plasma norepinephrine response to stimulation in chronically treated and control animals, showing that the overall gain of the 2-adrenoceptor inhibitory loop in vascular sympathetic nerves was not affected. Plasma epinephrine concentration during electrical stimulation was also increased by chronic but not by acute clorgyline treatment. Chronic clorgyline treatment did not significantly affect the total systemic metabolic clearance rate of infused norepinephrine, thus the increased plasma norepinephrine response to stimulation reflects an increased release rate from sympathetic neurons.In rats treated chronically with clorgyline, the pressor response to norepinephrine in the presence of yohimbine (0.3 mg/kg) was significantly reduced, whereas the pressor response to guanabenz was unchanged. There was also no change in the guanabenz-induced inhibition of the tachycardic response to electrical stimulation. These results show that the enhanced norepinephrine release produced by chronic clorgyline treatment leads to down-regulation of post-synaptic 1-adrenoreceptors with no change in post-synaptic 2-adrenoceptors or in cardiac presynaptic 2-adrenoreceptors, and are in agreement with an intrasynaptic location of 1-adrenoceptors and an extra-synaptic location of 2-adrenoceptors in the rat vasculature. 相似文献
11.
R. Jackisch S. Moll T. J. Feuerstein G. Hertting 《Naunyn-Schmiedeberg's archives of pharmacology》1985,330(2):105-113
Summary
3H-Noradrenaline release in the rabbit hippocampus and its possible modulation via presynaptic dopamine receptors was studied. Hippocampal slices were preincubated with 3H-noradrenaline, continuously superfused in the presence of cocaine (30 mol/l) and subjected to electrical field stimulation. The electrically evoked tritium over-flow from the slices was reduced by 0.1 and 1 mol/l dopamine and apomorphine, but significantly enhanced by 10 mol/l apomorphine or by 0.1 and 1 mol/l bromocriptine. If the 2-adrenoceptor antagonist yohimbine (0.1 mol/l) was present throughout superfusion, the inhibitory effects of dopamine and apomorphine were more pronounced and even 10 mol/l apomorphine and 1 mol/l bromocriptine inhibited noradrenaline release. Qualitatively similar observations were made in the presence of another 2-antagonist, idazoxane (0.1 mol/l). In the presence of the D2-receptor antagonist domperidone (0.1 mol/l) the inhibitory effects of dopamine were almost abolished, whereas both apomorphine (>1 mol/l) and bromocriptine (>0.01 mol/l) greatly facilitated noradrenaline release. The D2-receptor agonist LY 171555 (0.1 and 1 mol/l) significantly reduced the evoked noradrenaline release whereas the D1-selective agonist SK & F 38393 was ineffective at similar concentrations. The effects of LY 171555 were abolished in the presence of domperidone (0.1 mol/l) but remained unchanged in the presence of yohimbine or idazoxane (0.1 mol/l, each).At 1 mol/l the D2-receptor antagonists domperidone and (-)sulpiride significantly increased the evoked noradrenaline release by about 10%. However, at this concentration, domperidone (but not (-)sulpiride) affected also basal tritium outflow. Bulbocapnine and the preferential D1-receptor antagonists SCH 23390 enhanced the evoked noradrenaline release already at 0.1 mol/l. Their marked facilitatory effects (50 to 60% increase at 1 mol/l) were reduced in the presence of idazoxane (0.1 mol/l) and almost abolished in the presence of 0.1 mol/l yohimbine, whereas the increase due to 1 mol/l (-)sulpiride persisted under these conditions.The evoked tritium efflux from rabbit hippocampal slices preincubated with 3H-serotonin was not affected by dopamine receptor agonists.From our results we conclude that hippocampal noradrenaline, but not serotonin release, is modulated via D2-dopamine receptors. In addition, our results provide evidence for more or less pronounced 2-adrenoceptor agonistic properties of dopamine and 2-adrenoceptor antagonistic properties of apomorphine, bromocriptine, SCH 23390 and bulbocapnine in this noradrenaline release model from CNS tissue. 相似文献
12.
L. C. Rump K. Wilde C. Bohmann P. Schollmeyer 《Naunyn-Schmiedeberg's archives of pharmacology》1992,345(3):300-308
Summary The effects of the classical dopamine DA2-receptor agonist quinpirole (LY 171555) and the recently characterized DA2-receptor agonist, carmoxirole (EMD 45609), on neurotransmission in rat isolated kidney were investigated. After preincubation with 3H-noradrenaline, the renal nerves were electrically stimulated. The stimulation induced (S-I) outflow of radioactivity was taken as an index of noradrenaline release. Quinpirole (0.3 mol/l) inhibited S-I outflow of radioactivity and pressor responses to renal nerve stimulation (RNS) at 1 Hz. Both effects of quinpirole were blocked by the DA2-receptor antagonist S(–)-sulpiride (10 mol/l). The 1, 2-adrenoceptor antagonist phentolamine (1 mol/l) did not block the inhibitory effect of quinpirole. Carmoxirole (0.003 and 0.03 mol/l) did not alter and carmoxirole (0.3 mol/l) even enhanced S-I outflow of radioactivity, however, pressor responses to RNS were markedly reduced by carmoxirole (0.003–0.3 mol/l). Pressor responses to RNS were also markedly reduced by the 1-adrenoceptor antagonist prazosin (0.1 mol/l). Carmoxirole (0.3 mol/l), prazosin (0.1 mol/l) and phentolamine (1 mol/l) totally abolished pressor responses to exogenous noradrenaline (0.05 mol/l). In contrast, quinpirole (0.3 mol/l) did not alter pressor responses to exogenous noradrenaline (0.05 mol/l). Furthermore, carmoxirole (0.003–0.3 mol/l) markedly reduced pressor responses induced by the 1-adrenoceptor agonist methoxamine (1 mol/l) but even the highest concentration of carmoxirole (0.3 mol/l) had no effect on pressor responses induced by bolus injections of either neuropeptide Y (1.5 ng) or angiotensin II (1 ng). Phentolamine (1 mol/l) by itself markedly enhanced S-1 outflow of radioactivity and pressor responses to RNS were virtually unchanged. In the presence of phentolamine carmoxirole (0.03 and 0.3 mol/l) and quinpirole inhibited S-I outflow of radioactivity and pressor responses to RNS. Phentolamine resistant pressor responses to RNS were also inhibited by the P2X-receptor desensitizing agent , -methylene adenosine triphosphate (mATP, 1 mol/l), which by itself in the presence of phentolamine did not alter S-I outflow of radioactivity. The inhibitory effects of carmoxirole (0.3 mol/l) in the presence of phentolame (1mol/l) were antagonized by S(–)-sulpiride (10 mol/l). The data suggest that activation of prejunctional DA2-receptors by quinpirole inhibits noradrenaline release and thereby reduces pressor response to RNS at 1 Hz in rat isolated kidney. Carmoxirole activates prejunctional inhibitory DA2-receptors, but this effect is masked by simultaneous blockade of inhibitory prejunctional -adrenoceptors. Pressor responses to RNS at 1 Hz in rat isolated kidney are largely due to neuronally released noradrenaline whereas phentolamine resistant pressor responses to RNS at 1 Hz are most likely due to ATP, which is co-released with noradrenaline. Carmoxirole inhibits pressor responses to RNS at 1 Hz as well as pressor responses induced by either exogenous noradrenaline or methoxamine by blocking postjunctional 1-adrenoceptors. In addition carmoxirole and quinpirole seem to block phentolamine resistant pressor responses by inhibiting ATP release through activation of prejunctional DA2-receptors.
Send offprint requests to L. C. Rump at the above address 相似文献
13.
T. Mochizuki A. Yamatodani K. Okakura M. Takemura N. Inagaki H. Wada 《Naunyn-Schmiedeberg's archives of pharmacology》1991,343(2):190-195
Summary Using an in vivo intracerebral microdialysis method coupled with an HPLC-fluorometric method, we investigated the extracellular level of endogenous histamine in the anterior hypothalamic area of urethaneanaesthetized rats. The basal rate of release of endogenous histamine in the anterior hypothalamic area measured by this method was 0.09 + 0.01 pmol/20 min. When the anterior hypothalamic area was depolarized by infusion of 100 mM K+ through the dialysis membrane or electrical stimulation at 200 A was applied through an electrode implanted into the ipsilateral tuberomammillary nucleus, histamine release increased to 175% and 188%, respectively, of the basal level. These increases were completely suppressed by removal of extracellular Ca2+. The basal release of histamine was also suppressed after infusion of 10–6 M tetrodotoxin or i.p. administration of 100 mg/kg of -fluoromethylhistidine. On the other hand, 3-fold increase in the basal release was observed after i. p. administration of 5 mg/kg thioperamide. These results clearly indicate that both the basal and evoked release of histamine measured by our method are of neuronal origin.
Send offprint requests to T. Mochizuki at the above address 相似文献
14.
Jan Abrahamsen Ove A. Nedergaard 《Naunyn-Schmiedeberg's archives of pharmacology》1991,343(2):161-165
Summary The aim of the present investigation was to examine whether or not presynaptic facilitatory -adrenoceptors are detectable on the postganglionic nerves in the rabbit isolated ear artery. Strips of rabbit central ear artery were incubated with 3H-noradrenaline (10–7 mol/l; 30 min or 10–6 mol/l; 60 min). Subsequently, they were washed repeatedly with physiological salt solution. The strips were subjected to electrical-field stimulation (S1–S8) and the resultant 3H-overflow was determined.When the ear artery was stimulated with 150 pulses (0.5 ms; 3 Hz; 225 mA), isoprenaline (10–9–10–6 mol/l) either alone or in the presence of either rauwolscine (10–6 mol/l) or phentolamine (10–6 mol/l) did not alter the stimulation-evoked 3H-overflow. This was also the case in the presence of rauwolscine (10–6 mol/l) plus either the selective phosphodiesterase inhibitor ICI 63 197 (3 × 10–5 mol/l) or forskolin (10–6 mol/l). When the ear artery was stimulated with 300 pulses (1 ms; 5 Hz; 225 mA), isoprenaline had no effect on the stimulation-evoked 3H-overflow. This was also the case when phentolamine (10–6 mol/l) was present. Propranolol (10–7–10–5 mol/l) did not alter the stimulation-evoked 3H-overflow. In some experiments, the stimulation current was reduced to 175 mA in order to obtain similar reference release (S3) values despite the presence of rauwolscine (150 pulses; 0.5 ms; 3 Hz). Even then, isoprenaline (10–9–10–6 mol/l) did not change stimulation-evoked 3H-overflow. The results suggest that postganglionic sympathetic nerves in rabbit central ear artery do not possess presynaptic facilitatory -adrenoceptors.
Send offprint requests to J. Abrahamsen at the above address 相似文献
15.
J. C. Reubi P. C. Emson T. M. Jessell L. L. Iversen 《Naunyn-Schmiedeberg's archives of pharmacology》1978,304(3):271-275
Summary The effects of GABA, substance P and dopamine on the release of newly synthesized 3H-5-HT were investigated, using slices of rat substantia nigra superfused with l-3H-tryptophan in vitro. GABA (50 M) had no inhibitory effect on the potassium-evoked-release of 3H-5-HT. Substance P (50 M) and eledoisin (50 M) stimulated the spontaneous release of 3H-5-HT. This effect seems to be indirect and is possibly mediated by dopaminergic neurones, since the dopamine antagonist drug -flupenthixol (1 M) abolished the substance P-evoked release of 5-HT. Furthermore, it was found that substance P (10 M) stimulated 3H-dopamine release from nigral slices in vitro and the dopaminergic agonist apomorphine (50 M) also stimulated 3H-5-HT release. Substance P may, therefore, activate nigral dopaminergic neurones which then release dopamine from their dendrites. The release of dopamine may in turn stimulate 5-HT release from terminals of the raphe-nigral pathway. 相似文献
16.
Summary The effect of the indirect sympathomimetic agent tyramine on the isoprenaline-induced increase in plasma renin concentration was investigated in conscious rats. Tyramine caused a dose-dependent decrease in the isoprenaline-induced elevation of plasma renin concentration. Pretreatment of the rats with reserpine abolished this effect of tyramine, indicating that tyramine released catecholamines which acted on the inhibitory adrenoceptors. Pretreatment with phenoxybenzamine, an -adrenoceptor antagonist, also abolished the inhibitory effect of tyramine on renin release, indicating that -adrenoceptors mediated the observed inhibition of renin release.In rats with chronically denervated kidneys tyramine did not inhibit renin release. It is concluded that catecholamines which are released from renal sympathetic nerve endings can suppress renin release by activating -adrenoceptors.Supported by DFG Me 541/1 相似文献
17.
Joop C. van Oene Jan B. de Vries Alan S. Horn 《Naunyn-Schmiedeberg's archives of pharmacology》1984,327(4):304-311
Summary The influence of various -adrenoceptor antagonists (10 mg/kg i.p.) upon the rate of turnover of dopamine (DA) in the rat brain was investigated. Taking the levels of the DA metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) as a measure of the rate of DA turnover, it was found that prazosin and phenoxybenzamine decreased, whereas piperoxane and yohimbine increased the turnover rate both in the corpus striatum and in the tuberculum olfactorium. Azapetine, phentolamine and tolazoline as well as the -adrenoceptor antagonist propranolol were without a significant effect, whereas the DA antagonist haloperidol increased DOPAC and HVA levels and decreased the levels of DA itself.The possibility that the yohimbine-induced increase in the DA turnover rate was produced by a direct blockade of DA autoreceptors, was investigated under conditions where influences other than those elicited via DA autoreceptors are thought to be eliminated, i.e. in rats treated with reserpine or -butyrolactone (GBL). In rats that were pretreated with reserpine, yohimbine (10 mg/kg i.p.) was found to be ineffective in antagonizing the reduction of the accumulation of 3,4-dihydroxyphenylalanine (DOPA) following decarboxylase inhibition, that was produced by the DA agonist apomorphine (2.0 mg/kg i.p.). In rats pretreated with reserpine, yohimbine (10 mg/kg i.p.) was also ineffective in antagonizing the reduction of the DOPAC and HVA levels produced by apomorphine (2.0 mg/kg i.p.), but it was effective in antagonizing the reduction of the HVA level that was produced by the selective DA autoreceptor agonist N,N-di-n-propyl-7-hydroxy-2-aminotetralin (DP-7-AT, 1.0 mg/kg i.p.). In rats treated with GBL and a decarboxylase inhibitor, apomorphine (2.0 mg/kg i.p.) and DP-7-AT (1.0 mg/kg i.p.) induced a maximal suppression of the GBL-induced increase in the accumulation of DOPA. The effects of both apomorphine and DP-7-AT were partially inhibited by yohimbine (10 mg/kg i.p.). In inhibiting the effect of DP-7-AT, yohimbine appeared to be 100–200 times less effective than the DA antagonist haloperidol when both antagonists were administered at a fixed pretreatment time (1 h). It is concluded that yohimbine does indeed possess direct central DA autoreceptor blocking properties in vivo, and that this has to be taken into consideration if yohimbine is used as a pharmacological tool in order to achieve a selective blockade of 2-adrenoceptors. 相似文献
18.
A. Nistri 《Naunyn-Schmiedeberg's archives of pharmacology》1976,293(3):269-276
Summary The isolated frog spinal cord preparation, hemisected longitudinally, has been used to study concurrently the release of endogenous acetylcholine (ACh) and the electrical responses to stimulation of the ventral or dorsal roots. In unstimulated cords, ACh release was high initially and then fell to a plateau level. ACh release was reduced by tetrodotoxin and increased by high K+. Stimulation of the ventral roots enhanced the ACh release. The magnitude of this effect was dependent on the frequency of stimulation and was antagonized by tetrodotoxin or Ca2+-free Ringer. During prolonged ventral root stimulation (50 min), the evoked ACh release became progressively smaller but was restored to the original high levels by the addition of choline to the bath fluid. Stimulation of the dorsal roots failed to augment the ACh output. The application of hyoscine was followed by a large rise in the unstimulated ACh output. However no increase in the antidromically-evoked release, when compared with control stimulations, was seen. The application on -bungarotoxin was followed by a short-lasting decline in the unstimulated ACh output, whereas the electrically-evoked output was unaffected. In the frog spinal cord the determination of ACh release, together with the recording of the root potentials, offers the possibility of studying the output of a central transmitter in relation to the electrical activity of an in vitro central nervous system preparation. 相似文献
19.
Yoshihisa Koga Hall Downes Stephen M. Taylor 《Naunyn-Schmiedeberg's archives of pharmacology》1980,315(1):15-20
Summary The effects of dopamine (DA) were studied on guinea-pig isolated tracheal chains. At a low concentration (10–6M) DA occasionally produced a small contraction; this was followed by a dose-dependent relaxation 3×10–6–3×10–3 M).On a molar basis, DA was about 40 times less potent than noradrenaline (NA) in relaxing tracheal chains, and about 2700 times less potent than isoprenaline (ISO). The maximum degree of relaxation obtained with each drug was the same.Pretreatment of the guinea-pig with reserpine (5 mg/kg) resulted in a 3-fold shift of the DA curve to the right without concomitantly affecting the ISO doseresponse curve. Reserpine completely abolished the relaxant effects of tyramine, but a small contractile response remained.Desipramine (DMI), at a concentration of 10–5 M, caused a 4-fold shift of the DA curve to th right. The same concentration of DMI resulted in a shift to the left of the NA dose-response curve by about 8-fold. Benztropine (10–5 M) and haloperidol (10–5 M and 3×10–5 M) did not affect the DA dose-response curve.The DA-induced relaxation was inhibited by propranolol (10–8–10–6 M) in a dose-dependent manner. The higher concentrations of propranolol (10–7 and 10–6 M) unmasked the contractile effect of DA. In the presence of propranolol, phentolamine (10–5 M) abolished the contractile effect of DA.It is concluded that DA has both direct and indirect actions on guinea-pig isolated tracheal smooth muscle. The relaxant effects of DA are predominantly due to a direct action on smooth muscle -adrenoceptors, with a component due to release of NA from adrenergic nerves. The contractile effects, which under normal conditions are masked by the relaxant effect of DA, are mediated by functional -adrenoceptors. There is no evidence for either specific dopaminergic nerves, uptake mechanisms or receptors in guinea-pig trachealis muscle. 相似文献
20.
Bela Szabo Tobias Auberle Klaus Starke 《Naunyn-Schmiedeberg's archives of pharmacology》1993,348(3):249-257
Summary Inhibition of uptake, in the central nervous system leads to a decrease of sympathetic outflow to many tissues; central a2-adrenoceptors are involved in this decrease. The aim of the present study was to compare the effects of the selective uptake, inhibitor (+)-oxaprotiline on the plasma kinetics of noradrenaline and adrenaline in anaesthetized and in conscious rabbits. [3H]Noradrenaline and [3H]adrenaline were infused iv. The arterial plasma concentrations of endogenous and radiolabelled noradrenaline and adrenaline were measured, and the clearance from and spillover into the plasma of noradrenaline and adrenaline were calculated.Results obtained in conscious and anaesthetized rabbits were similar. (+)-Oxaprotiline 0.2, 0.6 and 1.8 mg kg–1 iv. dose-dependently reduced the clearance of [3H]noradrenaline from the plasma. The clearance of [3H]adrenaline was reduced less. The spillover of endogenous noradrenaline was decreased by up to 35%. In contrast, the spillover of adrenaline tended to be enhanced. Prazosin 0.1 and 1 mg kg–1 was injected iv. in a second part of each experiment. It lowered the blood pressure and caused a marked increase in noradrenaline spillover but no increase or even a decrease in adrenaline spillover.The results are compatible with the following hypothesis. The sympathetic outflow from the central nervous system is subject to a twofold a-adrenoceptor-mediated modulation: -adrenoceptor-mediated inhibition and 1-adrenoceptor-mediated excitation. In the control of the sympathetic outflow to many extra-adrenal tissues, the 2-adrenergic inhibition prevails. Uptake1 inhibitors depress sympathetic outflow to such tissues by enhancing the 2-adrenergic inhibition. In the regulation of the sympathetic outflow to the adrenal medulla, in contrast, 2-adrenergic inhibition and 1-adrenergic excitation have a similar impact. Uptake, inhibitors, hence, cause little change in adrenaline release: the two opposing influences cancel out. Prazosin produces an increase in noradrenaline but not adrenaline release because the loss of the central 1 sympathoexcitation attenuates at best slightly the baroreflex to most extra-adrenal tissues but dampens markedly the baroreflex to the adrenal medulla.
Correspondence to B. Szabo at the above address 相似文献